Möller S, Luecke C, Struffert T, Schwarze B, Gerner S, Schwab S, Köhrmann M, Machold K, Philipsen A, Mueller HH (2017)
Publication Type: Journal article
Publication year: 2017
Book Volume: 25
Pages Range: 127-130
DOI: 10.1016/j.ajp.2016.10.019
Synthetic cannabinoids, i.e. "spice", are psychoactive drugs with increasing use worldwide. Spice may have harmful neuropsychiatric and physical side effects. Here, we present the case of a 25-year-old man with ischemic stroke after smoking spice on the previous evening. Diagnostic work-up was negative for other common causes of stroke. Toxicology screen unveiled the cannabimimetic ADB-FUBINACA in the drug sample and in patient's urine. The cardiac sympathomimetic effect of spice might have triggered an unnoticed episode of tachyarrhythmia and resulted in stroke via cardioembolic etiology. Thus, in absence of other risk factors, a careful patient history of spice use is recommended for patients with acute neurological deficits.
APA:
Möller, S., Luecke, C., Struffert, T., Schwarze, B., Gerner, S., Schwab, S.,... Mueller, H.H. (2017). Ischemic stroke associated with the use of a synthetic cannabinoid (spice). Asian Journal of Psychiatry, 25, 127-130. https://doi.org/10.1016/j.ajp.2016.10.019
MLA:
Möller, Sebastian, et al. "Ischemic stroke associated with the use of a synthetic cannabinoid (spice)." Asian Journal of Psychiatry 25 (2017): 127-130.
BibTeX: Download